August 2026: Hormonal Health Issue
As hormones move from whispered concerns to mainstream wellness conversations, the supplement industry faces unprecedented opportunity in addressing reproductive health, sexual wellness, and life-stage transitions. In this issue, NBJ examines how the hormonal health landscape is being transformed by women's health advocacy, masculine wellness movements, metabolic science, and the convergence of supplements with bioidentical hormones and pharmaceutical interventions. From the fertility crisis driving the pre- and postnatal market toward $1.04 billion by 2029, to the manosphere's influence on testosterone optimization and the menopause market's growth toward $24.35 billion globally by 2030, this issue delivers comprehensive analysis of where cultural shifts, clinical evidence, and regulatory evolution intersect. Packed with market projections, expert perspectives, and ingredient deep dives into ashwagandha, omega-7, and adaptogens, the Hormonal Health issue reveals how brands can navigate sensitive topics, build trust through transparency, and create solutions addressing the interconnected nature of hormones, metabolism, stress, and healthy aging across both genders.
Who it's for: Product developers, brand strategists, women's health innovators, men's wellness marketers, fertility practitioners, and industry executives focused on hormone-adjacent formulations, life-stage nutrition, and building credibility in categories where consumer education and clinical validation are paramount.
What they'll learn: How metabolic health overlaps with fertility and sexual function, why the "34 symptoms" menopause model is obsolete, how manosphere influencer marketing creates both opportunities and regulatory risks, which ingredients are gaining traction for hormone support, and how to develop evidence-based, gender-specific products that meet sophisticated consumer demands across perimenopause, fertility challenges, testosterone optimization, and the hormone-longevity connection.